MODULATE INNATE IMMUNE RESPONSES TO CUSTOMIZE THERAPY IN ARID1A-DEFICIENT GASTRIC ADENOCARCINOMA

$2,021,389FY2022Department of the ArmyDOD

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators